We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Grafting Repairs Damaged Knee Cartilage

By HospiMedica staff writers
Posted on 31 Mar 2006
A new study shows that cartilage paste grafting can promote regeneration of cartilage tissue, and may be an effective and long-lasting treatment for arthritic knees. More...


In this prospective, longitudinal case series, 145 patients with a full-thickness chondral fracture in the knee (classified as an Outerbridge grade IV lesion) underwent 136 surgical procedures involving an articular cartilage paste graft. The mean age of the patients was 46 years, and 66% were men. Clinical data were recorded in 125 patients from two to 12 years postoperatively. A total of 66 patients underwent second-look arthroscopy, and cartilage biopsies were evaluated to qualify and quantify defect fill by a blinded, independent histopathology reviewer.

The review showed that validated pain, functioning, and activity measures improved significantly after surgery, and 104 (83.2%) of 125 patients were considered a clinical success. Of 18 surgical failures, 10 underwent subsequent joint arthroplasty, and eight reported worse pain after surgery. In the 66 biopsies performed, 63.6% showed strong and consistent evidence of replacement of the articular surface, while 27.3% revealed areas of cartilage indistinguishable from normal. The results were reported in the March 2006 issue of Arthroscopy.

This procedure offers excellent, long-lasting pain relief, restored functioning, and the possibility of tissue regeneration for patients with painful chondral lesions in arthritic knees, wrote Kevin R. Stone, M.D., and colleagues of The Stone Clinic (San Francisco, CA, USA).

Cartilage paste grafting involves formation of an osteocartilaginous paste from the intercondylar notch, which is subsequently injected into the chondral defect. This paste is thought to augment mesenchymal stem cell supply and improve the vascular supply to the damaged area, stimulating normal cartilage growth.



Related Links:
The Stone Clinic

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.